BD Onclarity™ HPV Assay with extended genotyping

Learn more about the benefits of extended genotyping and the BD Onclarity™ HPV Assay, the only FDA-approved HPV test with extended genotyping, that identifies genotypes beyond 16 and 18, including 31.

Latest resources

Discover our latest articles, webinars, press releases and updates in women's health.

Doctor giving patient brochure
Cervical Cancer | Articles & Publications
The Hill: What you can do to prevent cervical cancer
Chris Beddard, Vice President, U.S. Marketing, Integrated Diagnostic Solutions at BD
Cervical Cancer | News & Updates
NJBIZ Conversations: Chris Beddard
Molly Broache, Associate Director, Medical Affairs for US IDS discusses the future of cervical cancer screening
Cervical Cancer | News & Updates
Clinical Lab Products: The Future of Cervical Cancer Screening is Here